Q1 FY27 snapshot
Announcement Date10-Aug-26
Revenue (Top Line)₹162.97 Cr
Net Profit (Bottom Line)₹25.62 Cr
Earnings Per Share (EPS)₹24.7
Expenses₹ 121 Cr
Net profit margin (calculated)15.7%
Kwality Pharmaceuticals Ltd. (KPL) Quarterly Results: Q1 FY27
Quick answer: Kwality Pharmaceuticals Ltd. (NSE: KPL) reported Q1 FY27 revenue of ₹162.97 Cr and net profit of ₹25.62 Cr, with earnings per share (EPS) of ₹24.7, announced on 10-Aug-26.
That works out to a net profit margin of about 15.7% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Kwality Pharmaceuticals Ltd.'s Q1 FY27 results
Revenue of ₹162.97 Cr is what Kwality Pharmaceuticals Ltd. earned before costs. Net profit of ₹25.62 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 15.7%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Kwality Pharmaceuticals Ltd. results FAQs
What were Kwality Pharmaceuticals Ltd.'s Q1 FY27 results?
Kwality Pharmaceuticals Ltd. (NSE: KPL) reported Q1 FY27 revenue of ₹162.97 Cr and net profit of ₹25.62 Cr, with earnings per share (EPS) of ₹24.7, announced on 10-Aug-26.
What is Kwality Pharmaceuticals Ltd.'s EPS for Q1 FY27?
Kwality Pharmaceuticals Ltd.'s earnings per share for Q1 FY27 was ₹24.7. EPS is net profit divided by the number of outstanding shares.
When did Kwality Pharmaceuticals Ltd. announce its Q1 FY27 results?
Kwality Pharmaceuticals Ltd. announced its Q1 FY27 results on 10-Aug-26.
What is Kwality Pharmaceuticals Ltd.'s net profit margin?
On the reported figures, Kwality Pharmaceuticals Ltd.'s Q1 FY27 net profit margin is about 15.7% (net profit ÷ revenue).